Sign in

CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
202726770
Phone
862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-01-25 Roberts M Scot Chief Scientific Officer Shares withheld for taxes −4,264 $6.98 $30K 53,646
2025-01-25 Roberts M Scot Chief Scientific Officer Option exercise · Restricted Stock Units +14,600 43,800
2025-01-25 Jordt Raymond M Chief Business Officer Option exercise +14,600 36,150
2025-01-25 Jordt Raymond M Chief Business Officer Shares withheld for taxes −3,862 $6.98 $27K 32,288
2025-01-25 Jordt Raymond M Chief Business Officer Option exercise · Restricted Stock Units +14,600 43,800
2025-01-25 Harris Matthew Scott Chief Medical Officer Option exercise +14,600 69,719
2025-01-25 Harris Matthew Scott Chief Medical Officer Shares withheld for taxes −4,994 $6.98 $35K 64,725
2025-01-25 Harris Matthew Scott Chief Medical Officer Option exercise · Restricted Stock Units +14,600 43,800
2025-01-25 Garg Vipin K President and CEO Option exercise +42,050 334,078
2025-01-25 Garg Vipin K President and CEO Shares withheld for taxes −18,157 $6.98 $127K 315,921
2025-01-25 Garg Vipin K President and CEO Option exercise · Restricted Stock Units +42,050 126,150
2025-01-01 Jordt Raymond M Chief Business Officer Option exercise +9,375 24,035
2025-01-01 Jordt Raymond M Chief Business Officer Shares withheld for taxes −2,485 $7.21 $18K 21,550
2025-01-01 Jordt Raymond M Chief Business Officer Option exercise · Restricted Stock Units −9,375 18,750
2024-11-11 WEAVER GREGORY L Chief Financial Officer Grant or award · Stock Options (option to buy) +225,000 225,000
2024-11-11 WEAVER GREGORY L Chief Financial Officer Grant or award · Restricted Stock Units +75,000 75,000
2024-09-26 Pisano Wayne Director Grant or award · Stock Options (option to buy) +34,900 34,900
2024-09-26 Hodges Philip Director Grant or award · Stock Options (option to buy) +34,900 34,900
2024-09-26 SAYARE MITCHEL Director Grant or award · Stock Options (option to buy) +34,900 34,900
2024-09-26 Schafer Klaus Director Grant or award · Stock Options (option to buy) +34,900 34,900

Page 8 of 21 · 403 trades